These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 30415949)

  • 21. Telmisartan ameliorates insulin sensitivity by activating the AMPK/SIRT1 pathway in skeletal muscle of obese db/db mice.
    Shiota A; Shimabukuro M; Fukuda D; Soeki T; Sato H; Uematsu E; Hirata Y; Kurobe H; Maeda N; Sakaue H; Masuzaki H; Shimomura I; Sata M
    Cardiovasc Diabetol; 2012 Nov; 11():139. PubMed ID: 23137106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sirt1 activator induces proangiogenic genes in preadipocytes to rescue insulin resistance in diet-induced obese mice.
    Nawaz A; Mehmood A; Kanatani Y; Kado T; Igarashi Y; Takikawa A; Yamamoto S; Okabe K; Nakagawa T; Yagi K; Fujisaka S; Tobe K
    Sci Rep; 2018 Jul; 8(1):11370. PubMed ID: 30054532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reverse chemomodulatory effects of the SIRT1 activators resveratrol and SRT1720 in Ewing's sarcoma cells: resveratrol suppresses and SRT1720 enhances etoposide- and vincristine-induced anticancer activity.
    Sonnemann J; Kahl M; Siranjeevi PM; Blumrich A; Blümel L; Becker S; Wittig S; Winkler R; Krämer OH; Beck JF
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):17-26. PubMed ID: 26055805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Negative regulation of the deacetylase SIRT1 by DBC1.
    Zhao W; Kruse JP; Tang Y; Jung SY; Qin J; Gu W
    Nature; 2008 Jan; 451(7178):587-90. PubMed ID: 18235502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SIRT1 activator (SRT1720) improves the follicle reserve and prolongs the ovarian lifespan of diet-induced obesity in female mice via activating SIRT1 and suppressing mTOR signaling.
    Zhou XL; Xu JJ; Ni YH; Chen XC; Zhang HX; Zhang XM; Liu WJ; Luo LL; Fu YC
    J Ovarian Res; 2014 Oct; 7():97. PubMed ID: 25330910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DBC1 is a negative regulator of SIRT1.
    Kim JE; Chen J; Lou Z
    Nature; 2008 Jan; 451(7178):583-6. PubMed ID: 18235501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel SIRT1 activator MHY2233 improves glucose tolerance and reduces hepatic lipid accumulation in db/db mice.
    Kim MJ; An HJ; Kim DH; Lee B; Lee HJ; Ullah S; Kim SJ; Jeong HO; Moon KM; Lee EK; Yang J; Akter J; Chun P; Moon HR; Chung HY
    Bioorg Med Chem Lett; 2018 Feb; 28(4):684-688. PubMed ID: 29402742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation.
    Feige JN; Lagouge M; Canto C; Strehle A; Houten SM; Milne JC; Lambert PD; Mataki C; Elliott PJ; Auwerx J
    Cell Metab; 2008 Nov; 8(5):347-58. PubMed ID: 19046567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of SIRT1 activity by genotoxic stress.
    Yuan J; Luo K; Liu T; Lou Z
    Genes Dev; 2012 Apr; 26(8):791-6. PubMed ID: 22465953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The multifunctional sorting protein PACS-2 regulates SIRT1-mediated deacetylation of p53 to modulate p21-dependent cell-cycle arrest.
    Atkins KM; Thomas LL; Barroso-González J; Thomas L; Auclair S; Yin J; Kang H; Chung JH; Dikeakos JD; Thomas G
    Cell Rep; 2014 Sep; 8(5):1545-57. PubMed ID: 25159152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes.
    Milne JC; Lambert PD; Schenk S; Carney DP; Smith JJ; Gagne DJ; Jin L; Boss O; Perni RB; Vu CB; Bemis JE; Xie R; Disch JS; Ng PY; Nunes JJ; Lynch AV; Yang H; Galonek H; Israelian K; Choy W; Iffland A; Lavu S; Medvedik O; Sinclair DA; Olefsky JM; Jirousek MR; Elliott PJ; Westphal CH
    Nature; 2007 Nov; 450(7170):712-6. PubMed ID: 18046409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA TUG1 reduces inflammation and enhances insulin sensitivity in white adipose tissue by regulating miR-204/SIRT1 axis in obesity mice.
    Zhang Y; Gu M; Ma Y; Peng Y
    Mol Cell Biochem; 2020 Dec; 475(1-2):171-183. PubMed ID: 32888158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DBC1 phosphorylation by ATM/ATR inhibits SIRT1 deacetylase in response to DNA damage.
    Zannini L; Buscemi G; Kim JE; Fontanella E; Delia D
    J Mol Cell Biol; 2012 Oct; 4(5):294-303. PubMed ID: 22735644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic SirT1-Dependent Gain of Function of Stearoyl-CoA Desaturase-1 Conveys Dysmetabolic and Tumor Progression Functions.
    Qiang L; Kon N; Zhao W; Jiang L; Knight CM; Welch C; Pajvani U; Gu W; Accili D
    Cell Rep; 2015 Jun; 11(11):1797-808. PubMed ID: 26074075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SRT1720 attenuates obesity and insulin resistance but not liver damage in the offspring due to maternal and postnatal high-fat diet consumption.
    Nguyen LT; Chen H; Mak C; Zaky A; Pollock C; Saad S
    Am J Physiol Endocrinol Metab; 2018 Aug; 315(2):E196-E203. PubMed ID: 29533740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effects of SRT1720 on the apoptosis of rabbit chondrocytes by activating SIRT1 via p53/bax and NF-κB/PGC-1α pathways.
    Liu B; Lei M; Hu T; Yu F; Xiao DM; Kang H
    J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):350-355. PubMed ID: 27376802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabinoid-1 Receptor Antagonism Improves Glycemic Control and Increases Energy Expenditure Through Sirtuin-1/Mechanistic Target of Rapamycin Complex 2 and 5'Adenosine Monophosphate-Activated Protein Kinase Signaling.
    Liu J; Godlewski G; Jourdan T; Liu Z; Cinar R; Xiong K; Kunos G
    Hepatology; 2019 Apr; 69(4):1535-1548. PubMed ID: 30506571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The SIRT1 activator SRT1720 extends lifespan and improves health of mice fed a standard diet.
    Mitchell SJ; Martin-Montalvo A; Mercken EM; Palacios HH; Ward TM; Abulwerdi G; Minor RK; Vlasuk GP; Ellis JL; Sinclair DA; Dawson J; Allison DB; Zhang Y; Becker KG; Bernier M; de Cabo R
    Cell Rep; 2014 Mar; 6(5):836-43. PubMed ID: 24582957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptide switch is essential for Sirt1 deacetylase activity.
    Kang H; Suh JY; Jung YS; Jung JW; Kim MK; Chung JH
    Mol Cell; 2011 Oct; 44(2):203-13. PubMed ID: 22017869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice.
    Yamazaki Y; Usui I; Kanatani Y; Matsuya Y; Tsuneyama K; Fujisaka S; Bukhari A; Suzuki H; Senda S; Imanishi S; Hirata K; Ishiki M; Hayashi R; Urakaze M; Nemoto H; Kobayashi M; Tobe K
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1179-86. PubMed ID: 19724016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.